XKRX
084650
Market cap30mUSD
Oct 08, Last price
2,775.00KRW
1D
-3.81%
1Q
-26.59%
Jan 2017
-67.98%
IPO
316.25%
Name
Labgenomics Co Ltd
Chart & performance
P/E
—
P/S
0.47
EPS
—
Div yield, %
—
Shrs. gr., 5y
-25.77%
Rev. gr., 5y
-5.90%
Revenues
88.16b
+2.63%
Net income
-64.37b
L+170.53%
CFO
-30.54b
L+134.99%
Dividend
Dec 28, 2022200 KRW/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
LabGenomics Co., Ltd. is a specialist in genetic molecular diagnostics, providing a diverse array of related products and services. The company's offerings encompass advanced technologies such as Next Generation Sequencing (NGS) and general Molecular Diagnostics. This enterprise was established on March 29, 2002, and its principal offices are located in Seongnam-si, South Korea.
Key people
Internal Auditor · since 2023
Ji Wung Choi
Director · since 2023
Myeong Sin Kim
Director · since 2022
Jae Hak Ryu
Chief Executive Officer, Director · since 2025
Yu Chan Kim
Non-Executive Independent Director · since 2023
Gyu Yeong Kim
Non-Executive Independent Director · since 2023
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||